戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 ( right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 large CO2 removal capacities, and low regeneration energies are needed to achieve these separations efficiently at scale.
2 e importance of this structure, it is unknown which factors are needed to activate cumulus specific gene expression.
3 lation and more detailed estimates of mortality differences are needed to address this public health issue.
4                                              Future studies are needed to address whether similar mechanisms contribute t
5 uss how basic developmental studies have contributed to and are needed to advance clinical goals.
6 oints, potential new endpoints, as well as what new markers are needed to assess the ability of HBV therapeutics to achie
7                                Larger scale clinical trials are needed to assess the efficacy of gammaT supplements as a
8 al models and biomarkers of progression in patients with RP are needed to assess therapeutic outcomes.
9                                             Further studies are needed to better assess its safety and applicability.
10         Efficient wide-bandgap (WBG) perovskite solar cells are needed to boost the efficiency of silicon solar cells to
11                                             Further studies are needed to confirm and refine these recommendations.
12 pulation of patients undergoing longer duration of sedation are needed to confirm these observations.
13                                         Prospective studies are needed to define the impact of pretransplant sensitizatio
14                                              New strategies are needed to design future therapies that target resistant c
15                                       More reliable methods are needed to determine MGMT activity as DNA methylation, the
16                                             Further studies are needed to determine the life course progression of these
17                           Further rigorous clinical studies are needed to determine their efficacy and safety, as well as
18                                                     Studies are needed to determine whether these features of PDACs with
19 iscuss the future directions of research and reporting that are needed to diminish it.
20                                             Further studies are needed to elucidate the source and epidemiology of PCR ri
21                                            Novel strategies are needed to enhance muscle repair and function and to slow
22                                   Further follow-up studies are needed to establish the long-term safety of these strateg
23                                             Further studies are needed to evaluate the clinical implications of our findi
24                                             Further studies are needed to evaluate the mechanism of and opportunities for
25                                    However, further studies are needed to evaluate whether the control of metabolic param
26                                             Further studies are needed to explain the residual part of the spatial variab
27 roaches combining regulatory networks (RN) and genomic data are needed to extract biological information for a better und
28                                        New analytical tools are needed to fill the void for detection and visualization o
29                                             Further studies are needed to fully explore the complement of diversity and r
30           Given the wide-scale use of neonics, more studies are needed to fully understand their effects on human health.
31 ined by program director attitudes, although larger studies are needed to further define program factors affecting attrit
32              Additional high-quality interventional studies are needed to further evaluate the effectiveness of patient-
33                                                Better tools are needed to identify patients at high risk of developing HF
34                                                 New methods are needed to identify promising drug candidates earlier in t
35  in the pentamer, three anaesthetic-sensitive rho1 subunits are needed to impart full efficacy to the partial GABA agonis
36                                       Integrated strategies are needed to improve access to and uptake of HIV testing, ca
37                                               Interventions are needed to increase high-intensity statin use and adherenc
38                                                   More data are needed to inform next steps in the responsible stewardshi
39                                               Future trials are needed to investigate further the use of DSM265 for the p
40                                             Further studies are needed to investigate the role of specific genes involved
41                                                More studies are needed to investigate the use of bone turnover markers fo
42 inatal HIV transmission and missed prevention opportunities are needed to monitor progress toward elimination of mother-t
43  state of the art, cells of different material compositions are needed to produce devices of tailor made characteristics.
44                         Therefore, highly sensitive methods are needed to quantify BPA in various matrices including wate
45 rces and better collaboration with the affected populations are needed to realise the benefits of existing interventions.
46                                               Interventions are needed to safeguard the health of women after fistula rep
47  growth and consolidation (15-19 years), when new responses are needed to support brain maturation, intense social engage
48 rs is probably inevitable, and novel therapeutic approaches are needed to target dormant tumors.
49               High-resolution structures of metalloamyloids are needed to understand the molecular bases of metal-amyloid
50 e longitudinal studies with multiple postoperative measures are needed to validate the effect of these potential biomarke

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。